Grail (GRAL) Total Non-Current Liabilities (2023 - 2026)
Grail's (GRAL) quarterly Total Non-Current Liabilities came in at $297.9 million in Q2 2026, down 22.69% on a YoY basis from $385.3 million in Q2 2025, and down 0.66% quarter-over-quarter from $299.8 million in Q1 2026.
Analysis
Grail (GRAL) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Total Non-Current Liabilities for 4 consecutive years, with $297.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities fell 22.69% year-over-year to $297.9 million; the trailing twelve-month figure through Jun 2026 stood at $297.9 million (down 22.69% YoY), and the FY2025 full-year result was $341.4 million, down 28.53% from the prior year.
- Total Non-Current Liabilities retreated to $297.9 million in Q2 2026 per GRAL's latest filing, from $299.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $572.5 million in Q2 2024 and bottomed at $266.1 million in Q4 2023.
- Historically, Total Non-Current Liabilities has averaged $395.9 million across 4 years, with a median of $371.8 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities surged 79.49% in 2024, then sank 32.7% in 2025.
- Over 4 years, Total Non-Current Liabilities stood at $266.1 million in 2023, then soared by 79.49% to $477.7 million in 2024, then decreased by 28.53% to $341.4 million in 2025, then dropped by 12.75% to $297.9 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $297.9 million, $299.8 million, and $341.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 715.49 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 8.06 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 9.19 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 2.01 Bn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 1.86 Bn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 584.41 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 2.59 Bn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 490.00 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | 297.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 297.86 Mn |
| Mar 31, 2026 | 299.84 Mn |
| Dec 31, 2025 | 341.40 Mn |
| Sep 30, 2025 | 358.27 Mn |
| Jun 30, 2025 | 385.29 Mn |
| Mar 31, 2025 | 431.51 Mn |
| Dec 31, 2024 | 477.67 Mn |
| Sep 30, 2024 | 528.06 Mn |
| Jun 30, 2024 | 572.51 Mn |
| Dec 31, 2023 | 266.13 Mn |